Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats

International Journal of Urology

Volumn 22, Issue 6, 2015, Pages 598-603

  Yildiz, Nurdan ^a   Alpay, Harika ^a   Tuğtepe, Halil ^a   Özdemir Kumral, Zarife Nigar ^a   Akakin, Dilek ^a   Ilki, Arzu ^a   Şener, Göksel ^b   Yeğen, Berrak Ç ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Cystitis; Detrusor hypercontractility; Hyaluronic acid; Inflammation; Rats

Indexed keywords

CARBACHOL; CATALASE; GENTAMICIN; HYALURONIC ACID; MYELOPEROXIDASE; PAPAVERINE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; ANTIINFECTIVE AGENT; IMMUNOLOGICAL ADJUVANT; PEROXIDASE; URINARY TRACT AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTITIS; CYSTITIS INDUCED HYPERCONTRACTILITY; DRUG EFFECT; ENZYME ACTIVITY; ESCHERICHIA COLI INFECTION; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; INFLAMMATORY CELL; LAMINA PROPRIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY EFFECT; TREATMENT DURATION; ANIMAL; BLADDER; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; MUSCLE CONTRACTION; MUSCLE RELAXATION; PATHOLOGY; WISTAR RAT;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTI-BACTERIAL AGENTS; CATALASE; CYSTITIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HYALURONIC ACID; MUSCLE CONTRACTION; MUSCLE RELAXATION; PEROXIDASE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; URINARY BLADDER; UROLOGICAL AGENTS;

EID: 84930376790     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12752     Document Type: Article

References (30)

1. Tarin T, Shinghal R, Shortliffe LMD. Pediatric Urinary Tract Infections. In: Gearhart JP, Rink RC, Mouriquand PDE (eds). Pediatric Urology, 2nd edn. Saunders, PA, Philadephia, 2010; 180-95.
2. Winiecka W, Zoch-Zwierz W, Wasilewska A et al. Evaluation of bladder instability in children with recurrent urinary tract infections. Med. Sci. Monit. 2002; 8: CR19-23.
3. Cicione A, Cantiello F, Ucciero G et al. Restoring the glycosaminoglycans layer in recurrent cystitis: Experimental and clinical foundations. Int. J. Urol. 2014; 21: 763-8.
4. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271: 751-4.
5. Schulman CC, Corbusier A, Michiels H, Taenzer HJ. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J. Urol. 1993; 150: 917-21.
6. Lee DG, Cho JJ, Park HK et al. Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. Urology 2010; 75: 949-54.
7. Constantinides C, Manousakas T, Nikolopoulos P, Stanitsas A, Haritopoulos K, Giannopoulos A. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int. 2004; 93: 1262-6.
8. Porru D, Campus G, Tudino D et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol. Int. 1997; 59: 26-9.
9. Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pflüger H. Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int. Urogynecol. J. 2008; 19: 717-21.
10. Manas A, Glaria L, Pena C et al. Prevention of urinary tract infection in palliative radiation for vertebral metastasis and spinal compression: a pilot study in 71 patients. Int. J. Radiat. Oncol. Biol. Phys. 2006; 64: 935-40.
11. Chintea CL, Belal M. Is there enough evidence for the use of intravesical instillation of glycosaminoglycan analogues in interstitial cystitis? BJU Int. 2013; 111: 192-3.
12. Lv YS, Yao YS, Lin ME et al. Interleukin-6 levels in female rats with protamine sulfate-induced chronic cystitis treated with hyaluronic acid. Int. J. Urol. 2013; 20: 1017-22.
13. Tasdemir S, Tasdemir C, Vardi N et al. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model. Int. J. Urol. 2012; 19: 1108-12.
14. Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982; 78: 206-9.
15. Damiano R, Quarto G, Bava I et al. Prevention of Recurrent Urinary Tract Infections by Intravesical Administration of Hyaluronic Acid and Chondroitin Sulphate: A Placebo-Controlled Randomised Trial. Eur. Urol. 2011; 59: 645-51.
16. Lipovac M, Kurz C, Reithmayr F et al. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int. J. Gynecol. Obstet. 2006; 96: 192-5.
17. Iavazzo C, Athanasiou S, Pitsouni E, Falagas ME. Hyaluronic Acid: An Effective Alternative Treatment of Interstitial Cystitis, Recurrent Urinary Tract Infections, and Hemorrhagic Cystitis? Eur. Urol. 2007; 51: 1534-41.
18. Ruggieri MR, Hanno PM, Samadzadeh S, Johnson EW, Levin RM. Heparin inhibition of increased bacterial adherence following overdistension, ischemia and partial outlet obstruction of the rabbit urinary bladder. J. Urol. 1986; 136: 132-5.
19. Parsons CL. Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J. Urol. 1982; 127: 167-9.
20. Kyker KD, Coffman J, Hurst RE. Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder. BMC Urol. 2005; 5: 4.
21. Takahashi K, Takeuchi J, Takahashi T et al. Effects of sodium hyaluronate on epithelial healing of the vesical mucosa and vesical fibrosis in rabbits with acetic acid induced cystitis. J. Urol. 2001; 166: 710-3.
22. Pavlova EL, Lilova MI, Savov VM. Oxidative stress in children with kidney disease. Pediatr. Nephrol. 2005; 20: 1599-604.
23. Biyikli NK, Tugtepe N, Sener G et al. Oxytocin alleviates oxidative renal injury in pyelonephritic rats via neutrophil-dependent mechanism. Peptides 2006; 27: 2249-57.
24. Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr. Nephrol. 1991; 5: 733-42.
25. Jerde TJ, Bjorling DE, Steinberg H, Warner T, Saban R. Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide. Urol. Res. 2000; 28: 269-73.
26. Abraham P, Rabi S, Selvakumar D, Abraham P, Rabi S, Selvakumar D. Protective effect of aminoguanidine against oxidative stress and bladder injury in cyclophosphamide-induced hemorrhagic cystitis in rat. Cell Biochem. Funct. 2009; 27: 56-62.
27. Zhan CD, Sindhu RK, Pang J, Ehdaie A, Vaziri ND. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J. Hypertens. 2004; 22: 2025-33.
28. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int. J. Cancer 2008; 123: 601-8.
29. Weng TI, Chen WJ, Wu HY, Liu SH. Uropathogenic Escherichia coli alters muscle contractions in rat urinary bladder via a nitric oxide synthase-related signaling pathway. J. Infect. Dis. 2006; 194: 1774-82.
30. Yeh CH, Chiang HS, Chien CT. Hyaluronic acid ameliorates bladder hyperactivity via the inhibition of H2O2-enhanced purinergic and muscarinic signaling in the rat. Neurourol. Urodyn. 2010; 29: 765-70.